Drug Interaction Report

Colchicine and Ritonavir: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Ritonavir

Norvir
+

Colchicine

Colcrys Colcrys® Gloperba Gloperba® Lodoco Mitigare
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Contraindicated
These should generally not be used together.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 223 documented Colchicine interactions, 103 are rated contraindicated — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be stronger
The Bottom Line
Ritonavir sharply raises colchicine levels and can cause fatal toxicity, so full-dose colchicine with ritonavir is contraindicated. Do not combine them at normal doses without your care team lowering and individualizing the colchicine dose.

Ritonavir can make colchicine build up in your body, and that can be dangerous. Your body normally breaks down and clears colchicine using an enzyme (CYP3A4) and a transporter (P-gp). Ritonavir blocks both of these, so colchicine levels can climb much higher than intended. Too much colchicine can cause severe, even life-threatening problems, so taking the usual dose of both together is not recommended.

The good news is that this is well known and your care team can manage it. Please don't stop either medicine on your own. Talk with your pharmacist or doctor, because your colchicine dose may need to be lowered or your regimen adjusted to keep you safe.

Interaction: Ritonavir is a dual strong CYP3A4 and P-gp inhibitor; colchicine is a substrate of both. Co-administration reduces colchicine clearance, increasing exposure and risk of life-threatening/fatal toxicity. Direction: increased colchicine effect. Evidence: established.

  • Contraindicated in patients with renal or hepatic impairment, and at therapeutic colchicine doses.
  • In normal renal/hepatic function, dose reduction is required (including if ritonavir taken within prior 14 days).
  • Gout flare: 0.6 mg once, then 0.3 mg 1 hour later; do not repeat sooner than every 3 days.
  • Prophylaxis: reduce accordingly (e.g., 0.6 mg BID to 0.3 mg daily; 0.6 mg daily to 0.3 mg every other day).
  • FMF: max 0.6 mg/day.

Monitor for GI, neuromuscular, and hematologic toxicity.

Onset
unspecified
Evidence
established
Severity
Contraindicated

What happens

Increased colchicine exposure and an increased risk of colchicine toxicity

Interaction Deep Dive

Both CYP3A4 and P-gp metabolize colchicine, which serves as a substrate for each. Because fatal and life-threatening colchicine toxicity has been documented in patients taking therapeutic doses, giving colchicine together with agents that strongly inhibit both CYP3A4 and P-gp, such as ritonavir, is contraindicated1. In addition, combining colchicine with ritonavir is contraindicated when a patient has renal or hepatic impairment3. Patients whose renal and hepatic function is normal, but who are currently taking ritonavir or have taken it within the previous 14 days, must have their colchicine dose modified. When managing a gout flare while ritonavir is being taken, the modified oral colchicine regimen consists of a single 0.6 mg dose, then 0.3 mg one hour afterward, with repetition permitted no sooner than once every 3 days. For gout prophylaxis, an originally planned oral dose of 0.6 mg twice daily should be reduced to 0.3 mg once daily, while an originally planned oral dose of 0.6 mg once daily should be reduced to 0.3 mg every other day. For patients with familial Mediterranean fever taking ritonavir, colchicine should not exceed a maximum oral dose of 0.6 mg per day (which may be administered as 0.3 mg twice daily)42.

Why it happens (mechanism)

Inhibition of CYP3A4-mediated metabolism of colchicine; inhibition of P-gp-mediated efflux transport of colchicine

How to manage this interaction

This combination needs your care team's oversight. Standard colchicine doses with ritonavir are not recommended, and the combination is avoided entirely if you have kidney or liver problems.

  • Keep taking both only as prescribed and do not adjust doses yourself.
  • Your team may lower your colchicine dose and space it out. For example, dosing for a gout flare or daily prevention is typically reduced when ritonavir is on board (including if you took ritonavir in the last 14 days).
  • Watch for and report muscle weakness, numbness, severe diarrhea, vomiting, or unusual bruising.

Ask your pharmacist or prescriber to confirm the right colchicine dose for you.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

2 reports — tap to read

a) In a study involving 18 patients, taking a 0.6 mg dose of colchicine together with ritonavir 100 mg twice daily over 5 days produced increases from baseline of 184.4% in colchicine Cmax and 296% in colchicine AUC 2.

b) In a study involving 23 patients, taking a 0.6 mg dose of colchicine together with clarithromycin 250 mg twice daily over 7 days produced increases from baseline of 227.2% in colchicine Cmax and 281.5% in colchicine AUC 2.

Common questions

Can I take Colchicine and Ritonavir together?

Ritonavir sharply raises colchicine levels and can cause fatal toxicity, so full-dose colchicine with ritonavir is contraindicated. Do not combine them at normal doses without your care team lowering and individualizing the colchicine dose. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Colchicine and Ritonavir interaction?

It is rated contraindicated. These should generally not be used together.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Colchicine and Ritonavir interaction managed?

This combination needs your care team's oversight. Standard colchicine doses with ritonavir are not recommended, and the combination is avoided entirely if you have kidney or liver problems. Keep taking both only as prescribed and do not adjust doses yourself. Your team may lower your colchicine dose and space it out. For example, dosing for a gout flare or daily prevention is typically reduced wh… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

Questions for your pharmacist

  • Does my dose of Colchicine or Ritonavir need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (4)

  1. Product Information: LODOCO(R) oral tablets, colchicine oral tablets. AGEPHA Pharma USA, LLC (per FDA), Parsippany, NJ, 2023. DailyMed
  2. Product Information: COLCRYS oral tablets, colchicine oral tablets. Takeda Pharmaceuticals America Inc (per FDA), Deerfield, IL, 2020. DailyMed
  3. Product Information: GLOPERBA(R) oral solution, colchicine oral solution. Romeg Therapeutics LLC (per FDA), Woburn, MA, 2019. DailyMed
  4. Product Information: NORVIR(R) oral tablets, oral solution, ritonavir oral tablets, oral solution. AbbVie Inc. (per manufacturer), North Chicago, IL, 2016. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.